News
The publication in PLOS ONE shows that NAV-001 has robust single-dose efficacy against multiple mesothelin-expressing cancers and that tumor-produced Humoral Immunology-Oncology (HIO) factors ...
TMT Insights has announced the appointment of Nav Khangura as new VP of sales and business development across the EMEA regions. Incoming VP of sales and business development at TMT Insights, Nav ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback